387 related articles for article (PubMed ID: 34270926)
1. Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity.
Pearson JD; Huang K; Pacal M; McCurdy SR; Lu S; Aubry A; Yu T; Wadosky KM; Zhang L; Wang T; Gregorieff A; Ahmad M; Dimaras H; Langille E; Cole SPC; Monnier PP; Lok BH; Tsao MS; Akeno N; Schramek D; Wikenheiser-Brokamp KA; Knudsen ES; Witkiewicz AK; Wrana JL; Goodrich DW; Bremner R
Cancer Cell; 2021 Aug; 39(8):1115-1134.e12. PubMed ID: 34270926
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
[TBL] [Abstract][Full Text] [Related]
3. Mechanical control of the mammalian circadian clock via YAP/TAZ and TEAD.
Abenza JF; Rossetti L; Mouelhi M; Burgués J; Andreu I; Kennedy K; Roca-Cusachs P; Marco S; García-Ojalvo J; Trepat X
J Cell Biol; 2023 Sep; 222(9):. PubMed ID: 37378613
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
[TBL] [Abstract][Full Text] [Related]
5. Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis.
Hicks-Berthet J; Ning B; Federico A; Tilston-Lunel A; Matschulat A; Ai X; Lenburg ME; Beane J; Monti S; Varelas X
Cell Rep; 2021 Jul; 36(2):109347. PubMed ID: 34260916
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex.
Gibault F; Sturbaut M; Coevoet M; Pugnière M; Burtscher A; Allemand F; Melnyk P; Hong W; Rubin BP; Pobbati AV; Guichou JF; Cotelle P; Bailly F
ChemMedChem; 2021 Sep; 16(18):2823-2844. PubMed ID: 34032019
[TBL] [Abstract][Full Text] [Related]
7. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
[TBL] [Abstract][Full Text] [Related]
8. Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers.
Luo M; Xu Y; Chen H; Wu Y; Pang A; Hu J; Dong X; Che J; Yang H
Eur J Med Chem; 2022 Dec; 244():114847. PubMed ID: 36265280
[TBL] [Abstract][Full Text] [Related]
9. Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent.
Sekine S; Takase S; Hayase R; Noritsugu K; Maemoto Y; Ichikawa Y; Ogawa K; Kondoh Y; Osada H; Yoshida M; Ito A
Biosci Biotechnol Biochem; 2023 Apr; 87(5):501-510. PubMed ID: 36809780
[TBL] [Abstract][Full Text] [Related]
10. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
[TBL] [Abstract][Full Text] [Related]
12. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
Lui JW; Moore SPG; Huang L; Ogomori K; Li Y; Lang D
Pigment Cell Melanoma Res; 2022 Jan; 35(1):52-65. PubMed ID: 34468072
[TBL] [Abstract][Full Text] [Related]
13. ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.
Esposito D; Pant I; Shen Y; Qiao RF; Yang X; Bai Y; Jin J; Poulikakos PI; Aaronson SA
Nat Commun; 2022 Feb; 13(1):703. PubMed ID: 35121738
[TBL] [Abstract][Full Text] [Related]
14. CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.
Guo Y; Zhu Z; Huang Z; Cui L; Yu W; Hong W; Zhou Z; Du P; Liu CY
Nat Commun; 2022 Aug; 13(1):4995. PubMed ID: 36008411
[TBL] [Abstract][Full Text] [Related]
15. Decoding YAP dependent transcription in the liver.
Biagioni F; Croci O; Sberna S; Donato E; Sabò A; Bisso A; Curti L; Chiesa A; Campaner S
Nucleic Acids Res; 2022 Aug; 50(14):7959-7971. PubMed ID: 35871292
[TBL] [Abstract][Full Text] [Related]
16. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present).
Zagiel B; Melnyk P; Cotelle P
Expert Opin Ther Pat; 2022 Aug; 32(8):899-912. PubMed ID: 35768160
[TBL] [Abstract][Full Text] [Related]
17. Aberrant epithelial polarity cues drive the development of precancerous airway lesions.
Tilston-Lunel A; Mazzilli S; Kingston NM; Szymaniak AD; Hicks-Berthet J; Kern JG; Abo K; Reid ME; Perdomo C; Wilson AA; Spira A; Beane J; Varelas X
Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903236
[TBL] [Abstract][Full Text] [Related]
18. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.
Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857
[TBL] [Abstract][Full Text] [Related]
19. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
Saunders JT; Holmes B; Benavides-Serrato A; Kumar S; Nishimura RN; Gera J
J Neurooncol; 2021 Apr; 152(2):217-231. PubMed ID: 33511508
[TBL] [Abstract][Full Text] [Related]
20. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth.
Ong YT; Andrade J; Armbruster M; Shi C; Castro M; Costa ASH; Sugino T; Eelen G; Zimmermann B; Wilhelm K; Lim J; Watanabe S; Guenther S; Schneider A; Zanconato F; Kaulich M; Pan D; Braun T; Gerhardt H; Efeyan A; Carmeliet P; Piccolo S; Grosso AR; Potente M
Nat Metab; 2022 Jun; 4(6):672-682. PubMed ID: 35726026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
